FDA authorizes a 2nd pill to treat COVID-19
Another pill to treat COVID-19 is on the way.
The Food and Drug Administration on Thursday granted emergency use authorization to a pill to treat COVID-19 from Merck for adults who are at high risk of severe disease and "for whom alternative COVID-19 treatment options authorized by the FDA are not accessible or clinically appropriate." Molnupiravir is intended to be taken within five days of the onset of symptoms.
The pill isn't authorized for patients younger than 18 because it "may affect bone and cartilage growth," and it isn't authorized "for initiation of treatment in patients hospitalized due to COVID-19 because benefit of treatment has not been observed in people when treatment started after hospitalization due to COVID-19," the FDA said. Merck previously said the pill cut the risk of hospitalization and death by 30 percent.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
"Today's authorization provides an additional treatment option against the COVID-19 virus in the form of a pill that can be taken orally," FDA Center for Drug Evaluation and Research director Dr. Patrizia Cavazzoni said. "Molnupiravir is limited to situations where other FDA-authorized treatments for COVID-19 are inaccessible or are not clinically appropriate and will be a useful treatment option for some patients with COVID-19 at high risk of hospitalization or death."
This came a day after the FDA granted emergency use authorization to a COVID-19 pill from Pfizer, although the White House noted it will take months for it to become widely available. As with the Pfizer pill, the FDA stressed that neither of these treatments are substitutes for COVID-19 vaccines.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Brendan worked as a culture writer at The Week from 2018 to 2023, covering the entertainment industry, including film reviews, television recaps, awards season, the box office, major movie franchises and Hollywood gossip. He has written about film and television for outlets including Bloody Disgusting, Showbiz Cheat Sheet, Heavy and The Celebrity Cafe.
-
'Being more nuanced will not be easy for public health agencies'
Instant Opinion Opinion, comment and editorials of the day
By Justin Klawans, The Week US Published
-
Where did Democratic voters go?
Voter turnout dropped sharply for Democrats in 2024
By Joel Mathis, The Week US Published
-
4 tips to save as health care costs rise
The Explainer Co-pays, prescription medications and unexpected medical bills can really add up
By Becca Stanek, The Week US Published
-
ACA opens 2025 enrollment, enters 2024 race
Speed Read Mike Johnson promises big changes to the Affordable Care Act if Trump wins the election
By Peter Weber, The Week US Published
-
McDonald's sued over E. coli linked to burger
Speed Read The outbreak has sickened at least 49 people in 10 states and left one dead
By Rafi Schwartz, The Week US Published
-
Long Covid: study shows damage to brain's 'control centre'
The Explainer Research could help scientists understand long-term effects of Covid-19 as well as conditions such as MS and dementia
By The Week UK Published
-
FDA OKs new Covid vaccine, available soon
Speed read The CDC recommends the new booster to combat the widely-circulating KP.2 strain
By Peter Weber, The Week US Published
-
Mpox: how dangerous is new health emergency?
Today's Big Question Spread of potentially deadly sub-variant more like early days of HIV than Covid, say scientists
By The Week UK Published
-
What is POTS and why is it more common now?
The explainer The condition affecting young women
By Devika Rao, The Week US Published
-
Brexit, Matt Hancock and black swans: five takeaways from Covid inquiry report
The Explainer UK was 'unprepared' for pandemic and government 'failed' citizens with flawed response, says damning report
By Harriet Marsden, The Week UK Published
-
Should masks be here to stay?
Talking Points New York Governor Kathy Hochul proposed a mask ban. Here's why she wants one — and why it may not make sense.
By Anya Jaremko-Greenwold, The Week US Published